Cita APA

Haluska, P., Worden, F., Olmos, D., Yin, D., Schteingart, D., Batzel, G. N., . . . Hammer, G. D. (2009). Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma.

Citación estilo Chicago

Haluska, Paul, et al. Safety, Tolerability, and Pharmacokinetics of the Anti-IGF-1R Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma. 2009.

Cita MLA

Haluska, Paul, et al. Safety, Tolerability, and Pharmacokinetics of the Anti-IGF-1R Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma. 2009.